Correction to "Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design". (2020)

First Author: Pereira SGT
Attributed to:  Engineering Multi-functional Nanomaterials to Treat Metastatic Cancer funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.0c00676

PubMed Identifier: 32657590

Publication URI: http://europepmc.org/abstract/MED/32657590

Type: Journal Article/Review

Volume: 17

Parent Publication: Molecular pharmaceutics

Issue: 8

ISSN: 1543-8384